<p>Geometric mean (95% CI) of absolute pre-course and end-course VBLL for all courses nested by village and patient, by treatment dose regimen.</p
PURPOSE: To correctly evaluate realistic treatment plans in terms of absorbed dose to the clinical t...
a<p>Treatment duration = [(the study treatment end date)−(the first study drug start date)+1]/7.</p>...
<p>Abbreviations: PGTVnx = planning target volume for gross tumor volume; PCTV1 = planning target vo...
<p>Data are ECP (95% CI). See <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal....
<p>The baseline calculated geometric mean (GM) viral load (VL), GM VL 95% confidence interval (CI), ...
<p>Unadjusted end-course VBLL as a percentage of pre-course VBLL (ECP) by pre-course VBLL (μg/dl) (<...
Geometric means for SB, LPA and MVPA in minutes/day and percentage of waking hours.</p
<p>Geometric mean of IgG antibody concentrations (µg/mL) before and after vaccination with PCV-7 in ...
<p>Observed mean LOS, observed and predicted geometric LOS, p value for difference in observed and p...
<p>Geometric mean and median of 10,000 events obtained by flow cytometry for different cell lines an...
<p>Geometric means of A. 3-HPMA and B. HMPMA in the five ethnic groups, after adjusting for age, sex...
<p>Geometric mean titres, seropositivity rates, and proportions of seroresponders to rVSVΔG-ZEBOV-GP...
<p>Geometric mean titer of nAb from HIV-1 plasma samples B, B/Bbr, C and F1 against psVs.</p
<p>Geometric mean meningococcal serogroup A IgG antibody concentrations (95% CI) by age and country....
<p>Unadjusted and adjusted ratio of geometric means for volumetric absolute mammographic density by ...
PURPOSE: To correctly evaluate realistic treatment plans in terms of absorbed dose to the clinical t...
a<p>Treatment duration = [(the study treatment end date)−(the first study drug start date)+1]/7.</p>...
<p>Abbreviations: PGTVnx = planning target volume for gross tumor volume; PCTV1 = planning target vo...
<p>Data are ECP (95% CI). See <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal....
<p>The baseline calculated geometric mean (GM) viral load (VL), GM VL 95% confidence interval (CI), ...
<p>Unadjusted end-course VBLL as a percentage of pre-course VBLL (ECP) by pre-course VBLL (μg/dl) (<...
Geometric means for SB, LPA and MVPA in minutes/day and percentage of waking hours.</p
<p>Geometric mean of IgG antibody concentrations (µg/mL) before and after vaccination with PCV-7 in ...
<p>Observed mean LOS, observed and predicted geometric LOS, p value for difference in observed and p...
<p>Geometric mean and median of 10,000 events obtained by flow cytometry for different cell lines an...
<p>Geometric means of A. 3-HPMA and B. HMPMA in the five ethnic groups, after adjusting for age, sex...
<p>Geometric mean titres, seropositivity rates, and proportions of seroresponders to rVSVΔG-ZEBOV-GP...
<p>Geometric mean titer of nAb from HIV-1 plasma samples B, B/Bbr, C and F1 against psVs.</p
<p>Geometric mean meningococcal serogroup A IgG antibody concentrations (95% CI) by age and country....
<p>Unadjusted and adjusted ratio of geometric means for volumetric absolute mammographic density by ...
PURPOSE: To correctly evaluate realistic treatment plans in terms of absorbed dose to the clinical t...
a<p>Treatment duration = [(the study treatment end date)−(the first study drug start date)+1]/7.</p>...
<p>Abbreviations: PGTVnx = planning target volume for gross tumor volume; PCTV1 = planning target vo...